Galectin Therapeutics | GALT - Modal Saham Biasa

Keuangan

USD

USD 27.66M

USD 25.6M

USD 27.29M

Kewajiban Lancar

USD 14.62M

USD 71.74M

Dividen - Hasil

0

USD -9.17M

USD -7.43M

14

Eps Laba Per Saham

USD -0.2

Modal Dan Cadangan

USD -83.87M

Beban Bunga Utang

USD 1.27M

Pendapatan Bunga

USD -2.71M

USD 93.42M

Kapitalisasi Pasar

USD 184.8M

Batas Pemasukan

USD -12.37M

Biaya Operasional

USD 11.29M

Laba Operasional

USD -11.29M

Modal Saham Biasa

USD 61K

Laba Sebelum Pajak

USD -12.37M

Pendapatan Penjualan

4.02

Beban Penjualan Dan Administrasi

USD 1.48M

Kreditur Perdagangan

USD 3.7M

	Modal Saham Biasa	Perubahan		Tanggal
AbbVie	USD 1.77B		1.75B	2025-06
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Galectin Therapeutics	USD 61K		0	2023-12
Gilead Sciences	USD 1.24B		1000K	2026-06
Immunic	USD 120.38M		21.73M	2025-12
Incyte	USD 200.98M		1.03M	2026-06
Merck	USD 2.47B		4.93M	2026-03